StimuField™ Cap Technology Featured in Peer-Reviewed Brazilian Journal of Hair Health

Delaware, US; July 30th, 2025 

Microneedling, LLLT, PEMF, and Precision LLLT

Scientific review demonstrates promising results for non-invasive hair and scalp health solution based on technology adapted from NASA research

StimuSIL is proud to announce the publication of comprehensive research on the StimuField™ Cap, Evaluating ICES® PEMF Technology for Hair Growth: A Scientific Review of the StimuField Cap System”, in the prestigious Brazilian Journal of Hair Health. The article presents the scientific foundation and preliminary clinical evaluation of our innovative wearable scalp device utilizing ICES® PEMF technology.

Key Takeaways

The research explores how the StimuField™ Cap utilizes ICES® (Inductively Coupled Electrical Stimulation) PEMF technology, adapted from NASA research, to deliver electromagnetic waveforms designed to support hair and scalp wellness through non-invasive means.

Key findings from the 24-week pilot study include:

  • Users reported improvements in hair density and volume
  • Reduction in hair shedding reported by participants
  • Increases in terminal hair density observed
  • Demonstrated safety profile with no adverse effects

“This publication represents a major milestone in validating our technology through rigorous scientific review,” said CEO Ana Villalba, . “The results suggest that ICES PEMF may offer a promising non-pharmacological approach for supporting hair and scalp health in individuals experiencing mild to moderate hair thinning.”

The research emphasizes the StimuField™ Cap’s position as a safe approach that addresses the growing interest in non-drug solutions for hair and scalp wellness. The technology’s foundation in NASA research and adaptation for consumer wellness applications showcases StimuSIL’s commitment to science-backed innovation.

The study author, Chief Medical Officer Dr. Gerrish, note that while these preliminary results are encouraging, further randomized controlled trials are planned to establish optimal treatment protocols and long-term outcomes across broader patient populations. StimuSIL continues to support research and innovation in dermatology and aesthetics.

Click on the button below to learn more about Stimufield cap or download the article.